According to Santen Pharmaceutical 's latest financial reports the company's total assets are A$4.64 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | A$4.70 B | -6.3% |
2022-03-31 | A$5.02 B | 4.04% |
2021-03-31 | A$4.82 B | -21.27% |
2020-03-31 | A$6.13 B | 23.32% |
2019-03-31 | A$4.97 B | 4.57% |
2018-03-31 | A$4.75 B | 13.4% |
2017-03-31 | A$4.19 B | 1.6% |
2016-03-31 | A$4.12 B | 24.73% |
2015-03-31 | A$3.30 B | 32.7% |
2014-03-31 | A$2.49 B | 18.46% |
2013-03-31 | A$2.10 B | -8.89% |
2012-03-31 | A$2.31 B | 7.3% |
2011-03-31 | A$2.15 B | 10.51% |
2010-03-31 | A$1.94 B | -11.64% |
2009-03-31 | A$2.20 B | 28.56% |
2008-03-31 | A$1.71 B | 2.6% |
2007-03-31 | A$1.67 B | -7.62% |
2006-03-31 | A$1.81 B | 7.06% |
2005-03-31 | A$1.69 B |